For instance, in December 2024, the U.S
In animal studies, retatrutide produced the largest decreases in food intake compared to semaglutide, tirzepatide, and liraglutide individually
Animal data confirms increased nitrogen retention with LR3 IGF-1 (Tomas et al., 1993), but most of the visible scale movement during a 10-day cycle reflects increased intracellular water and glycogen rather than new contractile protein
Long-term safety is still being established through Phase 3 trials
In these clinical trials, peptides stimulating growth hormone release appeared to deliver some action in two ways possibly either via stimulating the pituitary gland to release growth hormones, or possibly acting on the arcuate nucleus of the hypothalamus